Sulopenem

DB15284InvestigationalSmall molecule

Sulopenem is a penem antibacterial. It is marketed as the prodrug sulopenem etzadroxil in combination with probenecid.

Mechanism: Pharmacologically active on Penicillin-binding protein
Curator reviewed
Formula / weight: C₁₂H₁₅NO₅S₃ · 349.43 g/mol (avg)
Code names: CP-65207-S · CP-70,429

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyFLSUCZWOEMTFAQ-PRBGKLEPSA-NSMILES[H][C@]12SC(S[C@H]3CC[S@@+]([O-])C3)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Sulopenem, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.